跳至主要内容
临床试验/NCT03704233
NCT03704233Unknown不适用

The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Diseases: a Prospective, Multicenter, Real World Study

Guangzhou Institute of Respiratory Disease26 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2018年11月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
350
试验地点
26
主要终点
Diagnotic yield

研究概览

简要总结

The Diagnostic yield and Safety of transbronchial cryobiopsy in the diagnosis of diffuse parenchymal lung diseases are investigated in this multicenter, prospective and real world study.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • The patients are admitted in the institution as DPLD, while undefined after thorough history collection, laboratory examination and radiological data.
  • Transbronchial cryobiopsy(TBCB) is indicated by clinicians for definitive diagnosis and patients are content with the examination with agreement signed.
  • Blood gas analysis, routine blood test, ECG examination, coagulation function, immunological examination, chest HRCT, and liver/kidney function test have been completed.

排除标准

  • The radiological data indicates non-DPLD
  • The clinical examinations mentioned above are not completed.
  • The patient cannot endure or does not agree the procedure.

结局指标

主要结局

Diagnotic yield

时间窗: two weeks

Percentage of definitive pathological diagnosis by transbronchial cryobiopsy, the alteration of original diagnosis after transbronchial cryobiopsy

次要结局

  • Complication rate(12 weeks)

研究者

发起方
Guangzhou Institute of Respiratory Disease
申办方类型
Other
责任方
Principal Investigator
主要研究者

ShiYue Li

Director of Department of Respiratory Medicine

Guangzhou Institute of Respiratory Disease

研究点 (26)

Loading locations...

相似试验